Phospholipase D1 facilitates second-phase myoblast fusion and skeletal muscle regeneration

Molecular Biology of the Cell

Volumn 26, Issue 3, 2015, Pages 506-517

  Teng, Shuzhi ^a,b   Stegner, David ^c   Chen, Qin ^d   Hongu, Tsunaki ^e   Hasegawa, Hiroshi ^e   Chen, Li ^b   Kanaho, Yasunori ^e   Nieswandt, Bernhard ^c   Frohman, Michael A ^d   Huang, Ping ^b,f  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b JILIN UNIVERSITY   (China)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d STONY BROOK UNIVERSITY   (United States)

^e UNIVERSITY OF TSUKUBA   (Japan)

^f BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOTOXIN; DYSTROPHIN; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDIC ACID; PHOSPHOLIPASE D1; COBROTOXIN; PHOSPHOLIPASE D;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL FUSION; CELL MEMBRANE; CHANNEL GATING; CONTROLLED STUDY; DOWN REGULATION; DUCHENNE MUSCULAR DYSTROPHY; ENZYME INHIBITION; IN VITRO STUDY; MOUSE; MUSCLE DEVELOPMENT; MUSCLE INJURY; MUSCLE REGENERATION; MYOBLAST; MYOTUBE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; UPREGULATION; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE; ANIMAL; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; KNOCKOUT MOUSE; PHYSIOLOGY; REGENERATION;

MUS;

ANIMALS; CELL DIFFERENTIATION; CELL FUSION; COBRA CARDIOTOXIN PROTEINS; GENE EXPRESSION REGULATION; MICE; MICE, KNOCKOUT; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MYOBLASTS, SKELETAL; PHOSPHOLIPASE D; REGENERATION; UP-REGULATION;

EID: 84921878961     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E14-03-0802     Document Type: Article

References (61)

1. Abmayr SM, Pavlath GK (2012). Myoblast fusion: lessons from flies and mice. Development 139, 641-656.
2. Bach AS, Enjalbert S, Comunale F, Bodin S, Vitale N, Charrasse S, Gauthier-Rouviere C (2010). ADP-ribosylation factor 6 regulates mammalian myoblast fusion through phospholipase D1 and phosphatidylinositol 4, 5-bisphosphate signaling pathways. Mol Biol Cell 21, 2412-2424.
3. Black BL, Olson EN (1998). Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol 14, 167-196.
4. Braun T, Bober E, Buschhausen-Denker G, Kohtz S, Grzeschik KH, Arnold HH (1989). Differential expression of myogenic determination genes in muscle cells: possible autoactivation by the Myf gene products. EMBO J 8, 3617-3625.
5. Cazzolli R, Huang P, Teng S, Hughes WE (2009). Measuring phospholipase D activity in insulin-secreting pancreatic beta-cells and insulin-responsive muscle cells and adipocytes. Methods Mol Biol 462, 241-251.
6. Chapman VM, Miller DR, Armstrong D, Caskey CT (1989). Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice. Proc Natl Acad Sci USA 86, 1292-1296.
7. Chen EH, Grote E, Mohler W, Vignery A (2007). Cell-cell fusion. FEBS Lett 581, 2181-2193.
8. Chen EH, Olson EN (2005). Unveiling the mechanisms of cell-cell fusion. Science 308, 369-373.
9. Chen Q, Hongu T, Sato T, Zhang Y, Ali W, Cavallo JA, van der Velden A, Tian H, Di Paolo G, Nieswandt B, et al. (2012). Key roles for the lipid signaling enzyme phospholipase d1 in the tumor microenvironment during tumor angiogenesis and metastasis. Sci Signal 5, ra79.
10. Chernomordik LV, Kozlov MM (2008). Mechanics of membrane fusion. Nat Struct Mol Biol 15, 675-683.
11. Cockcroft S (2001). Signalling roles of mammalian phospholipase D1 and D2. Cell Mol Life Sci 58, 1674-1687.
12. Cohen FS, Melikyan GB (2004). The energetics of membrane fusion from binding, through hemifusion, pore formation, and pore enlargement. J Membrane Biol 199, 1-14.
13. Colley WC, Sung TC, Roll R, Jenco J, Hammond SM, Altshuller Y, Bar-Sagi D, Morris AJ, Frohman MA (1997). Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr Biol 7, 191-201.
14. Dixon RW, Harris JB (1996). Myotoxic activity of the toxic phospholipase, notexin, from the venom of the Australian tiger snake. J Neuropathol Exp Neurol 55, 1230-1237.
15. Elvers M, Stegner D, Hagedorn I, Kleinschnitz C, Braun A, Kuijpers ME, Boesl M, Chen Q, Heemskerk JW, Stoll G, et al. (2010). Impaired alpha(IIb)beta(3) integrin activation and shear-dependent thrombus formation in mice lacking phospholipase D1. Sci Signal 3, ra1.
16. Han MS, Lim YM, Quan W, Kim JR, Chung KW, Kang M, Kim S, Park SY, Han JS, Park SY, et al. (2011). Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance. J Lipid Res 52, 1234-1246.
17. Harris JB, Johnson MA (1978). Further observations on the pathological responses of rat skeletal muscle to toxins isolated from the venom of the Australian tiger snake, Notechis scutatus scutatus. Clin Exp Pharmacol Physiol 5, 587-600.
18. Haslett JN, Kang PB, Han M, Kho AT, Sanoudou D, Volinski JM, Beggs AH, Kohane IS, Kunkel LM (2005). The influence of muscle type and dystrophin deficiency on murine expression profiles. Mamm Genome 16, 739-748.
19. Hasty P, Bradley A, Morris JH, Edmondson DG, Venuti JM, Olson EN, Klein WH (1993). Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 364, 501-506.
20. Horsley V, Jansen KM, Mills ST, Pavlath GK (2003). IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 113, 483-494.
21. Horsley V, Pavlath GK (2004). Forming a multinucleated cell: molecules that regulate myoblast fusion. Cells Tissues Organs 176, 67-78.
22. Huang F, Subbaiah PV, Holian O, Zhang J, Johnson A, Gertzberg N, Lum H (2005a). Lysophosphatidylcholine increases endothelial permeability: role of PKCalpha and RhoA cross talk. Am J Physiol Lung Cell Mol Physiol 289, L176-185.
23. Huang P, Altshuller YM, Hou JC, Pessin JE, Frohman MA (2005b). Insulin-stimulated plasma membrane fusion of Glut4 glucose transporter-containing vesicles is regulated by phospholipase D1. Mol Biol Cell 16, 2614-2623.
24. Hughes WE, Elgundi Z, Huang P, Frohman MA, Biden TJ (2004). Phospholipase D1 regulates secretagogue-stimulated insulin release in pancreatic beta-cells. J Biol Chem 279, 27534-27541.
25. Jaafar R, Zeiller C, Pirola L, Di Grazia A, Naro F, Vidal H, Lefai E, Nemoz G (2011). Phospholipase D regulates myogenic differentiation through the activation of both mTORC1 and mTORC2 complexes. J Biol Chem 286, 22609-22621.
26. Jenkins GM, Frohman MA (2005). Phospholipase D: a lipid centric review. Cell Mol Life Sci 62, 2305-2316.
27. Joe AW, Yi L, Natarajan A, Le Grand F, So L, Wang J, Rudnicki MA, Rossi FM (2010). Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nat Cell Biol 12, 153-163.
28. Komati H, Naro F, Mebarek S, De Arcangelis V, Adamo S, Lagarde M, Prigent AF, Nemoz G (2005). Phospholipase D is involved in myogenic differentiation through remodeling of actin cytoskeleton. Mol Biol Cell 16, 1232-1244.
29. Kozlovsky Y, Chernomordik LV, Kozlov MM (2002). Lipid intermediates in membrane fusion: formation, structure, and decay of hemifusion diaphragm. Biophys J 83, 2634-2651.
30. Lang T, Halemani ND, Rammner B (2008). Interplay between lipids and the proteinaceous membrane fusion machinery. Prog Lipid Res 47, 461-469.
31. Lawlor MW, Alexander MS, Viola MG, Meng H, Joubert R, Gupta V, Motohashi N, Manfready RA, Hsu CP, Huang P, et al. (2012). Myotubularin-deficient myoblasts display increased apoptosis, delayed proliferation, and poor cell engraftment. Am J Pathol 181, 961-968.
32. Leikina E, Melikov K, Sanyal S, Verma SK, Eun B, Gebert C, Pfeifer K, Lizunov VA, Kozlov MM, Chernomordik LV (2013). Extracellular annexins and dynamin are important for sequential steps in myoblast fusion. J Cell Biol 200, 109-123.
33. Leung DW (2001). The structure and functions of human lysophosphatidic acid acyltransferases. Front Biosci 6, D944-953.
34. Lewis JA, Scott SA, Lavieri R, Buck JR, Selvy PE, Stoops SL, Armstrong MD, Brown HA, Lindsley CW (2009). Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I: Impact of alternative halogenated privileged structures for PLD1 specificity. Bioorg Med Chem Lett 19, 1916-1920.
35. Li D, Yu L, Wu H, Shan Y, Guo J, Dang Y, Wei Y, Zhao S (2003). Cloning and identification of the human LPAAT-zeta gene, a novel member of the lysophosphatidic acid acyltransferase family. J Hum Genet 48, 438-442.
36. Liscovitch M, Czarny M, Fiucci G, Tang X (2000). Phospholipase D: molecular and cell biology of a novel gene family. Biochem J 345, 401-415.
37. Maltin CA, Harris JB, Cullen MJ (1983). Regeneration of mammalian skeletal muscle following the injection of the snake-venom toxin, taipoxin. Cell Tissue Res 232, 565-577.
38. Meriane M, Roux P, Primig M, Fort P, Gauthier-Rouviere C (2000). Critical activities of Rac1 and Cdc42Hs in skeletal myogenesis: antagonistic effects of JNK and p38 pathways. Mol Biol Cell 11, 2513-2528.
39. Mohandas N, Wyatt J, Mel SF, Rossi ME, Shohet SB (1982). Lipid translocation across the human erythrocyte membrane. Regulatory factors. J Biol Chem 257, 6537-6543.
40. Molkentin JD, Black BL, Martin JF, Olson EN (1995). Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83, 1125-1136.
41. Morris AJ, Frohman MA, Engebrecht J (1997). Measurement of phospholipase D activity. Anal Biochem 252, 1-9.
42. Nabeshima Y, Hanaoka K, Hayasaka M, Esumi E, Li S, Nonaka I, Nabeshima Y (1993). Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 364, 532-535.
43. Nakanishi H, de los Santos P, Neiman AM (2004). Positive and negative regulation of a SNARE protein by control of intracellular localization. Mol Biol Cell 15, 1802-1815.
44. Porter JD, Merriam AP, Leahy P, Gong B, Feuerman J, Cheng G, Khanna S (2004). Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy. Hum Mol Genet 13, 257-269.
45. Rando TA, Blau HM (1994). Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol 125, 1275-1287.
46. Rochlin K, Yu S, Roy S, Baylies MK (2010). Myoblast fusion: when it takes more to make one. Dev Biol 341, 66-83.
47. Roth MG (2008). Molecular mechanisms of PLD function in membrane traffic. Traffic 9, 1233-1239.
48. Santini MT, Indovina PL, Cantafora A, Blotta I (1990). The cesium-induced delay in myoblast membrane fusion is accompanied by changes in isolated membrane lipids. Biochim Biophys Acta 1023, 298-304.
49. Scott SA, Selvy PE, Buck JR, Cho HP, Criswell TL, Thomas AL, Armstrong MD, Arteaga CL, Lindsley CW, Brown HA (2009). Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Nat Chem Biol 5, 108-117.
50. Singer WD, Brown HA, Sternweis PC (1997). Regulation of eukaryotic phosphatidylinositol-specific phospholipase C and phospholipase D. Annu Rev Biochem 66, 475-509.
51. Sohn RL, Huang P, Kawahara G, Mitchell M, Guyon J, Kalluri R, Kunkel LM, Gussoni E (2009). A role for nephrin, a renal protein, in vertebrate skeletal muscle cell fusion. Proc Natl Acad Sci USA 106, 9274-9279.
52. Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panettieri RA, Petrof B, Narusawa M, Leferovich JM, Sladky JT, Kelly AM (1991). The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352, 536-539.
53. Su W, Yeku O, Olepu S, Genna A, Park JS, Ren H, Du G, Gelb MH, Morris AJ, Frohman MA (2009). 5-Fluoro-2-indolyl des-chlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis. Mol Pharmacol 75, 437-446.
54. Vicogne J, Vollenweider D, Smith JR, Huang P, Frohman MA, Pessin JE (2006). Asymmetric phospholipid distribution drives in vitro reconstituted SNARE-dependent membrane fusion. Proc Natl Acad Sci USA 103, 14761-14766.
55. Vitale N, Caumont AS, Chasserot-Golaz S, Du G, Wu S, Sciorra VA, Morris AJ, Frohman MA, Bader MF (2001). Phospholipase D1: a key factor for the exocytotic machinery in neuroendocrine cells. EMBO J 20, 2424-2434.
56. Wakelam MJ (1983). Inositol phospholipid metabolism and myoblast fusion. Biochem J 214, 77-82.
57. Wang L, Radu CG, Yang LV, Bentolila LA, Riedinger M, Witte ON (2005). Lysophosphatidylcholine-induced surface redistribution regulates signaling of the murine G protein-coupled receptor G2A. Mol Biol Cell 16, 2234-2247.
58. Xu Y, Rubin BR, Orme CM, Karpikov A, Yu C, Bogan JS, Toomre DK (2011). Dual-mode of insulin action controls GLUT4 vesicle exocytosis. J Cell Biol 193, 643-653.
59. Yoon MS, Chen J (2008). PLD regulates myoblast differentiation through the mTOR-IGF2 pathway. J Cell Sci 121, 282-289.
60. You JS, Lincoln HC, Kim CR, Frey JW, Goodman CA, Zhong XP, Hornberger TA (2014). The role of diacylglycerol kinase zeta and phosphatidic acid in the mechanical activation of mammalian target of rapamycin (mTOR) signaling and skeletal muscle hypertrophy. J Biol Chem 289, 1551-1563.
61. Zeniou-Meyer M, Zabari N, Ashery U, Chasserot-Golaz S, Haeberle AM, Demais V, Bailly Y, Gottfried I, Nakanishi H, Neiman AM, et al. (2007). Phospholipase D1 production of phosphatidic acid at the plasma membrane promotes exocytosis of large dense-core granules at a late stage. J Biol Chem 282, 21746-21757.